Information Provided By: 
Fly News Breaks for August 6, 2019
RVNC
Aug 6, 2019 | 11:22 EDT
After Revance reported Q2 results, H.C. Wainwright analyst Douglas Tsao noted that the company indicated, "most importantly," that it is on track to file the BLA for Daxi for the treatment of glabellar lines this fall. There had been some investor concern after the filing had been delayed, but now that it appears 'imminent,' investors can again focus on Daxi's "significant" commercial potential, said Tsao, who reiterates a Buy rating on Revance shares.
News For RVNC From the Last 2 Days
There are no results for your query RVNC
